Julie Kim
InvestorPresident, CEO and Representative Director (CEO-Elect) at Takeda Ventures
Boston and Tokyo
About
Julie Kim is president, CEO and representative director of Takeda, elected by shareholders and appointed by the Board of Directors in June 2026. She joined Takeda in 2019 via the Shire acquisition and held executive roles including president of the Plasma-Derived Therapies Business Unit and president of the U.S. Business Unit before becoming CEO-elect in 2025. Prior to Takeda, she held roles at Baxter, Baxalta and Shire across global, regional and country-level positions, and holds an MBA from Northwestern University's Kellogg School and a bachelor's in economics from Dartmouth College.
Experience
- TakedaPresident & CEOcurrent2026 — presentCambridge, MA
- TakedaCEO-Elect2026
- TakedaInterim Head Global Portfolio Division2025 — 2026
- TakedaPresident, U.S. Business Unit2022 — 2025Boston, Massachusetts, United States
- TakedaPresident, Plasma-Derived Therapies Business Unit2019 — 2022
- ShireGlobal Franchise Head, Hematology2018 — 2019Zug, Canton of Zug, Switzerland
- ShireHead of International Value Demonstration & Access2016 — 2018Zug, Switzerland
- BaxaltaHead of Business Model Innovation2015 — 2016London, United Kingdom
- BaxaltaCluster Head, Immunology, North/South Europe2015United Kingdom
- Baxter International Inc.General Manager, UK & Ireland2014London, England
- Baxter International Inc.Global Franchise Head, BioTherapeutics2010 — 2013Deerfield, IL
- Baxter International Inc.Vice President, Global Marketing, BioTherapeutics2009 — 2010Westlake Village, CA
- Baxter International Inc.Senior Director, Global Marketing, BioTherapeutics2005 — 2009Westlake Village, CA
- Baxter International Inc.Director, Global Expansion2003 — 2005Westlake Village, CA
- Baxter International Inc.Director, Strategy2001 — 2003Westlake Village, CA
- CSC HealthcareEngagement Manager1997 — 2000
- APM/CSC HealthcareEngagement Manager1992 — 2000
- APMAssociate1992 — 1995
Skills & more
Medical Devices23Program Management9Pharmaceutical Industry67Product Launch41Strategy53Cross-functional Team Leadership56Biotherapeutics33Product Development8FDA5Biotechnology27Global Marketing20Strategic Planning19
+12 more
Pharmaceutical SalesMarketing StrategySales EffectivenessProject ManagementMarket AccessCommercializationBusiness StrategyManagementLifesciencesClinical DevelopmentOncologyCompetitive AnalysisFrom Julie's professional profile.
Colleagues at Takeda Ventures
Akiko Amakawa
CEO Chief of Staff at Takeda Ventures
Andrew S. Plump
Director - President, Research & Development at Takeda Ventures
Asuka Miyabashira
President, Japan Pharma Business Unit at Takeda Ventures
Awny Farajallah
Chief Medical Officer at Takeda Ventures
Elaine Shannon
President, Global Supply & Quality at Takeda Ventures
Gabriele Ricci
Chief Data & Technology Officer at Takeda Ventures
Giles Platford
President, International Business Unit at Takeda Ventures
Jennifer Smoter
Chief Communications & Governance Officer at Takeda Ventures
Frequently asked questions
- Who is Julie Kim?
- Julie Kim is president, CEO and representative director of Takeda, elected by shareholders and appointed by the Board of Directors in June 2026. She joined Takeda in 2019 via the Shire acquisition and held executive roles including president of the Plasma-Derived Therapies Business Unit and president of the U.S. Business Unit before becoming CEO-elect in 2025. Prior to Takeda, she held roles at Baxter, Baxalta and Shire across global, regional and country-level positions, and holds an MBA from Northwestern University's Kellogg School and a bachelor's in economics from Dartmouth College.
- Where does Julie Kim work?
- Julie Kim is President, CEO and Representative Director (CEO-Elect) at Takeda Ventures.
- Where did Julie Kim go to school?
- Julie Kim studied at Northwestern University - Kellogg School of Management (Master of Business Administration (MBA)); Dartmouth College (Bachelor of Arts - BA).
Same school
Also attended Northwestern University - Kellogg School of Management577
Jenny LeeSenior Managing Partner at Granite AsiaKunal BahlCo-founder of Snapdeal; co-founder of Titan CapitalAndy FligelSenior Managing Director at Intel CapitalDavid Clark GuillermoInvestments at Impact America FundGiuseppe DonvitoPartner at P101 VenturesAntonio TurroniOperating Advisor at P101 Ventures
+ 571 more
Also attended Dartmouth College409
Tomasz TunguzFounder & General Partner at Theory VenturesScott SandellExecutive Chairman & Chief Investment Officer at NEAJames DetweilerVP of Investments at Felicis VenturesBen RobbinsInvestor at GV (Google Ventures)Mounisha AnumoluInvestor at GV (Google Ventures)Ren RileyAdvisor at Oak Investment Partners
+ 403 more
Shared employers
Also worked at Takeda33
Rebecca RedfieldSenior Associate at .406 VenturesAkiko AmakawaCEO Chief of Staff at Takeda VenturesAwny FarajallahChief Medical Officer at Takeda VenturesElaine ShannonPresident, Global Supply & Quality at Takeda VenturesGabriele RicciChief Data & Technology Officer at Takeda VenturesGiles PlatfordPresident, International Business Unit at Takeda Ventures
+ 27 more
Also worked at Shire13
Sun AltbachSenior Scientific Advisor at BOLD LongevityGabriele RicciChief Data & Technology Officer at Takeda VenturesRamy RiadPresident, Plasma-Derived Therapies Business Unit at Takeda VenturesJeffrey M. JonasPartner at Cure VenturesSun AltbachSenior Advisor BOLD Longevity at Bold Capital PartnersSusan KilsbyAdvisor at Siddhi Capital
+ 7 more
